Author

Tony E. Walshe

Alnylam Pharmaceuticals (United States)ORCID 0000-0001-7055-8251Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Approach:benchmark study· 1 Research Focus:database / resource· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Aaron M. HollemaniD· 1 shared Aimée M. DeatoniD· 1 shared Andrew Anh NguyeniD· 1 shared Anna Borodovsky· 1 shared Barrett D. Leehy· 1 shared Brynjolfur G. JonssoniD· 1 shared Chia Ling HuangiD· 1 shared Cynthia L. GrosskreutziD· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Aaron M. HollemanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintNov 13, 2024

Rare predicted loss-of-function and damaging missense variants in CFHR5 associate with protection from age-related macular degeneration

Aaron M. Holleman, Aimée M. Deaton, Rachel A. Hoffing…·Lucas D. Ward

The paper identifies rare variants in CFHR5 associated with reduced risk of AMD and increased retinal thickness, suggesting CFHR5 as a therapeutic target.

1 citation

humanwhole-exome sequencing

𝕏 PostBluesky

Genetic & Genomic MedicineNature CommunicationsPeer-reviewedJun 13, 2022

A Proteogenomic Signature of Age-related Macular Degeneration in Blood

Valur Emilsson, Elias Freyr Gudmundsson, Þórarinn Jónmundsson…·Tony E. Walshe

This study identifies a proteogenomic signature in blood associated with age-related macular degeneration, linking serum proteins to disease severity and progression.

42 citationstop 1%

humanproteomics

𝕏 PostBluesky